S 491
108th Congress
Senate
Health
Agriculture and Food
Ambulatory care
Animals
Clinical trials
Congress
Congressional investigations
Congressional reporting requirements
Department of Health and Human Services
Digestive diseases
Drug therapy
Economics and Public Finance
Education
Environmental Protection
Environmentally induced diseases
Epidemiology
Federal aid to research
Genetic research
Genetics
Government Operations and Politics
Inflammatory Bowel Disease Act
Introduced: February 27, 2003
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2003
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2977)
Feb 27, 2003
Sponsor introductory remarks on measure. (CR S2976-2977)
Feb 27, 2003
Introduced in Senate
Plain-English summary
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.
Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.
Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.
Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2977)
Committees of jurisdiction
1